Epigenetic modifications and targeted therapy in pediatric acute myeloid leukemia
Acute myeloid leukemia (AML) is a hematological malignancy resulting from the genetic alterations and epigenetic dysregulations of the hematopoietic progenitor cells. One-third of children with AML remain at risk of relapse even though outcomes have improved in recent decades. Epigenetic dysregulati...
Saved in:
Main Authors: | Huan Xu (Author), Yuxi Wen (Author), Runming Jin (Author), Hongbo Chen (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epigenetic Modifications in Pediatric Acute Lymphoblastic Leukemia
by: Michael James Burke, et al.
Published: (2014) -
New and Emerging Targeted Therapies for Pediatric Acute Myeloid Leukemia (AML)
by: Jing Chen, et al.
Published: (2020) -
Advances in targeted therapy for acute myeloid leukemia
by: Jifeng Yu, et al.
Published: (2020) -
Molecular landscape and targeted therapy of acute myeloid leukemia
by: Runxia Gu, et al.
Published: (2018) -
Traditional Chinese medicine for acute myelocytic leukemia therapy: exploiting epigenetic targets
by: Xinlong Gao, et al.
Published: (2024)